CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

Flu season is here and a covid uptick is around the corner. Two infectious diseases experts offer their tips on how to plan for vaccination against those viruses.

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

After a week of chaos and confusion, as Centers for Disease Control and Prevention employees described it, the fates of more ...

Alternative splicing exhibits lineage-specific variability, with mammals and birds reaching the highest levels despite conserved intron-rich architectures, while unicellular eukaryotes and prokaryotes ...

It's been like living in a washing machine, it's been constant chaos,” former NIH official Jeremy Berg said at the ...

The 15-governor alliance marks the largest coordinated state response to Trump's sweeping changes to public health policies.

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune response with even fewer side effects than either of these immunisation approaches ...

BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next ...

But recently, scientists took inspiration for such a super drug from a quiet corner of the medical world: The small subset of ...